Table of Contents
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Blood Purification Equipment Overview 10
3 Products under Development 11
3.1 Blood Purification Equipment – Pipeline Products by Stage of Development 11
3.2 Blood Purification Equipment – Pipeline Products by Territory 12
3.3 Blood Purification Equipment – Pipeline Products by Regulatory Path 14
3.4 Blood Purification Equipment – Pipeline Products by Estimated Approval Date 15
3.5 Blood Purification Equipment – Ongoing Clinical Trials 16
4 Blood Purification Equipment – Pipeline Products under Development by Companies 17
4.1 Blood Purification Equipment Companies – Pipeline Products by Stage of Development 17
4.2 Blood Purification Equipment – Pipeline Products by Stage of Development 18
5 Blood Purification Equipment Companies and Product Overview 20
5.1 Accel Diagnostics LLC Company Overview 20
5.1.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Aethlon Medical Inc Company Overview 21
5.2.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Asahi Kasei Medical Co Ltd Company Overview 25
5.3.1 Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Boston Children’s Hospital Company Overview 26
5.4.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Cerus Corp Company Overview 27
5.5.1 Cerus Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Chemofilter Inc (Inactive) Company Overview 34
5.6.1 Chemofilter Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Cook Regentec LLC Company Overview 36
5.7.1 Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 CytoSorbents Corp Company Overview 39
5.8.1 CytoSorbents Corp Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Delcath Systems Inc Company Overview 54
5.9.1 Delcath Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 54
5.10 EBO2 Inc Company Overview 59
5.10.1 EBO2 Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Ex Vivo Dynamics Inc Company Overview 60
5.11.1 Ex Vivo Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Good SIRS Company Overview 61
5.12.1 Good SIRS Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 HemoTune AG Company Overview 62
5.13.1 HemoTune AG Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Immunicom Inc Company Overview 63
5.14.1 Immunicom Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 McGowan Institute for Regenerative Medicine Company Overview 68
5.15.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 68
5.16 MediSieve Ltd Company Overview 69
5.16.1 MediSieve Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
5.17 Nipro Corp Company Overview 73
5.17.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 73
5.18 Nonwovens Innovation & Research Institute Ltd Company Overview 74
5.18.1 Nonwovens Innovation & Research Institute Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
5.19 NxStage Medical Inc Company Overview 75
5.19.1 NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75
5.20 Opsonix Inc Company Overview 76
5.20.1 Opsonix Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 Path Ex Inc Company Overview 77
5.21.1 Path Ex Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 ProSorp BioTech Inc Company Overview 78
5.22.1 ProSorp BioTech Inc Pipeline Products & Ongoing Clinical Trials Overview 78
5.23 Spectral Medical Inc Company Overview 79
5.23.1 Spectral Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79
5.24 Toray Medical Co Ltd Company Overview 82
5.24.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
5.25 Zata Pharmaceuticals Inc Company Overview 83
5.25.1 Zata Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 83
6 Blood Purification Equipment- Recent Developments 86
6.1 Nov 25, 2019: CytoSorbents changes Contract Research Organizations and temporarily pauses enrollment in REFRESH 2-AKI Study 86
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 86
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 88
6.4 Nov 06, 2019: Dr. Eric Mortensen to leave CytoSorbents at year end 89
6.5 Nov 05, 2019: CytoSorbents reports third quarter 2019 financial results 90
7 Appendix 199
7.1 Methodology 199
7.2 About GlobalData 202
7.3 Contact Us 202
7.4 Disclaimer 202
Table 1: Blood Purification Equipment - Pipeline Products by Stage of Development
Table 2: Blood Purification Equipment - Pipeline Products by Territory
Table 3: Blood Purification Equipment - Pipeline Products by Regulatory Path
Table 4: Blood Purification Equipment - Pipeline Products by Estimated Approval Date
Table 5: Blood Purification Equipment - Ongoing Clinical Trials
Table 6: Blood Purification Equipment Companies - Pipeline Products by Stage of Development
Table 7: Blood Purification Equipment - Pipeline Products by Stage of Development
Table 8: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 9: mPharesis - Product Status
Table 10: mPharesis - Product Description
Table 11: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: ASEPSYS Device - Product Status
Table 13: ASEPSYS Device - Product Description
Table 14: Hemopurifier - Product Status
Table 15: Hemopurifier - Product Description
Table 16: Aethlon Medical Inc - Ongoing Clinical Trials Overview
Table 17: Hemopurifier - An Early Feasibility Study of Hemopurifier in Patients with Head and Neck Cancer
Table 18: Hemopurifier - Plasma Exosome Concentration in Cancer Patients Undergoing Treatment
Table 19: Hemopurifier - Sepsis-related Virus Study of Aethlon Hemopurifier
Table 20: Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Mysorba - Product Status
Table 22: Mysorba - Product Description
Table 23: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Blood Filtration Device - Product Status
Table 25: Blood Filtration Device - Product Description
Table 26: Cerus Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: INTERCEPT Blood System - Platelets - Product Status
Table 28: INTERCEPT Blood System - Platelets - Product Description
Table 29: INTERCEPT Blood System - Red Blood Cells - Product Status
Table 30: INTERCEPT Blood System - Red Blood Cells - Product Description
Table 31: INTERCEPT Blood System - Zika Virus - Product Status
Table 32: INTERCEPT Blood System - Zika Virus - Product Description
Table 33: Cerus Corp - Ongoing Clinical Trials Overview
Table 34: INTERCEPT Blood System - Platelets - A Randomized, Multi-center, Multi-Stage, Controlled, In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days
Table 35: INTERCEPT Blood System - Red Blood Cells - A Randomized, Double-blinded, Controlled, Parallel Group, Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures
Table 36: INTERCEPT Blood System - Red Blood Cells - Measurement of the Recovery and Lifespan of Red Blood Cells from Pathogen-reduced, Stored Blood Units Using Cellular Biotinylation
Table 37: INTERCEPT Blood System - Red Blood Cells - Randomized, Double-blind, Controlled, Parallel Group Study with the INTERCEPT Blood System for RBCs in Regions at Potential Risk for Zika Virus Transfusion-transmitted Infections and Treatment Use Open-label Extension Study
Table 38: Chemofilter Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 39: ChemoFilter Device - Product Status
Table 40: ChemoFilter Device - Product Description
Table 41: Next-Generation ChemoFilter Device - Product Status
Table 42: Next-Generation ChemoFilter Device - Product Description
Table 43: Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 44: HemaTrate - Critical Limb Ischemia - Product Status
Table 45: HemaTrate - Critical Limb Ischemia - Product Description
Table 46: Cook Regentec LLC - Ongoing Clinical Trials Overview
Table 47: HemaTrate - Critical Limb Ischemia - Clinical Study of the Use of an Autologous Blood Filtration Device in the Treatment of Critical Limb Ischemia
Table 48: CytoSorbents Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 49: BetaSorb - Product Status
Table 50: BetaSorb - Product Description
Table 51: ContrastSorb - Product Status
Table 52: ContrastSorb - Product Description
Table 53: CST 301 - Product Status
Table 54: CST 301 - Product Description
Table 55: CytoSorb - Product Status
Table 56: CytoSorb - Product Description
Table 57: CytoSorb-XL - Product Status
Table 58: CytoSorb-XL - Product Description
Table 59: DrugSorb - Product Status
Table 60: DrugSorb - Product Description
Table 61: HemoDefend - Product Status
Table 62: HemoDefend - Product Description
List of Figures
Figure 1: Blood Purification Equipment - Pipeline Products by Stage of Development
Figure 2: Blood Purification Equipment - Pipeline Products by Territory
Figure 3: Blood Purification Equipment - Pipeline Products by Regulatory Path
Figure 4: Blood Purification Equipment - Pipeline Products by Estimated Approval Date
Figure 5: Blood Purification Equipment - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer